A 2-week old infant with Mpox in Uganda: a case report
Michael Derrick Ngobi1, Lucy Amaniyo2, Evelyn Kembabazi3
1Department of Paediatrics and Child Health, School of Medicine, College of Health Sciences, Kampala, Uganda. mdngobi@gmail.com.
Background:
The World Health Organization declared Mpox (formerly known as monkey pox) as a public health emergency of international concern in August 2024. Whereas Mpox primarily affects adults and children, neonatal case reports are rare. We present a case of Mpox in a 2-week-old neonate without prior known history of exposure, and whose mother's DNA polymerase chain reaction test was negative for Mpox.
Case Presentation:
A 2-week-old African female neonate presented to our emergency unit with 1-week history of high-grade fever and 4-day history of vesicular rash. The rash initially manifested as an erythematous macular rash on the forehead, then gradually transformed into a maculopapular rash, and finally into a vesicular rash that spread cephalocaudally, affecting even the palms and soles. There was no known history of exposure to a person with a similar rash. A real-time polymerase chain reaction test was done, which yielded a positive result for Mpox. The mother's Mpox polymerase chain reaction test was negative. No other family members were tested. The patient was managed in an isolation care center with emollients for skin care, exposure to control fevers, and prophylactic antibiotics to prevent secondary bacterial skin infections. The patient subsequently improved and was discharged in good condition from the care center after 11 days of hospitalization.
Conclusion:
This case highlights the need to increase the index of suspicion for Mpox even in neonates who present with no clear history of exposure and negative maternal Mpox polymerase chain reaction.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Drug Dosing: Infants and Children


